Form 4: Humana Director Brad D. Smith Reports Acquisition of Restricted Stock Units

Director Brad D. Smith reports acquisition of Humana Inc. restricted stock units related to director fees.

Summary

• On September 30, 2024, Brad D. Smith, a director at Humana Inc., reported the acquisition of restricted stock units (RSUs).
• These RSUs are related to director's fees and are deferred until his resignation, at which point they will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Smith acquired 102 RSUs as a result of electing to convert a cash fee into stock units at a price of $320.19.
• He also holds 380 RSUs from annual director's fees, 3 RSUs from a previous election, and 430 RSUs vesting on 12/31/24.
• Following the reported transaction, Smith beneficially owns 540 RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction indicating the director's continued investment in the company. There are no overtly negative implications.

Positives

• The acquisition of RSUs demonstrates the director's continued investment and alignment with the company's long-term success.

Future Outlook

The RSUs will be payable in Humana Inc. common stock upon the director's resignation of services.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's ongoing investment in the company.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash and equity, such as restricted stock units, to align their interests with those of shareholders.
• The vesting schedules and terms of these equity grants are typically disclosed in company filings and are comparable to those offered by other publicly traded companies in the healthcare industry.
• Companies like UnitedHealth Group (UNH) and CVS Health (CVS) also utilize similar equity-based compensation for their directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates the director's alignment with the company's long-term success.

Key Dates